Tarlatamab Shows Promise in Tackling Previously Treated SCLC Tarlatamab Shows Promise in Tackling Previously Treated SCLC

The investigational drug led to encouraging overall survival and intracranial disease control in patients with small-cell lung cancer, longer-term trial data suggested.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news